these observations ( negative patch test reactions , positive intradermal test reactions ) suggest that the route of administration may be an important determinant of antigenic hapten-protein complex formation and subsequent delayed hypersensitivity responses involving cutaneous or mucocutaneous tissue .
C0003316
determinant
C0018593
hapten